Lincoln Pharmaceuticals reports standalone net profit of Rs 17.38 crores in Q1FY22
EBITDA for Q1FY22 was reported at Rs 26.31 crores, a rise of 17.37 per cent as compared to EBITDA of Rs 22.42 crores in Q1FY21
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
AstraZeneca India’s Q1 net profit declines 45 per cent
Revenue from operations stood at Rs 175.40 crores for the quarter under consideration. It was Rs 193.57 crores for the same period…
Demystifying pharma procurement: Opportunities, challenges and way forward
Express Pharma, in association with SAP India, as part of the Life Sciences Industry Knowledge Exchange Forum, recently hosted a…
BioNTech says repeats of its COVID-19 vaccine better than devising new one, for now
The German biotech firm said that offering a third dose of its established two-shot vaccine remained the best response to concerns…
Philip Morris International acquires OtiTopic
This acquisition is part of PMI's strategic plan to leverage its expertise, scientific know-how and capabilities in inhalation to…
NPPA fixes retail prices for six formulations
The step has been taken based on the decision of the authority meeting held on 29th July, 2021
ICMR says Covaxin-Covishield combination shows better results
The study is yet to be peer-reviewed
AIkido provides update on use of machine learning in drug development programme
To support this goal, physics-based machine learning (ML) is being applied by SilcsBio LLC to accelerate the discovery of…
Researchers find potential drug against COVID-19 among tapeworm medications
The compound, part of a class of molecules called salicylanilides, was designed in the laboratory by a team of researchers from…
US FDA approves Nexviazyme for late-onset Pompe disease
The approval is based on the positive phase-III data demonstrating improvements in key disease burden measures and establishing…